(Q54908034)

English

NCI-H322M

cell line

NCI.H322M
H322M
H-322M

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

parent cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

HLA class I and II genotype of the NCI-60 cell lines

1 reference

Cellosaurus release 49

14 July 2024

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

Cellosaurus release 49

14 July 2024

DNA fingerprinting of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

14 July 2024

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 49

14 July 2024

Identification of cancer cell-line origins using fluorescence image-based phenomic screening

1 reference

Cellosaurus release 49

14 July 2024

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

Cellosaurus release 49

14 July 2024

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

1 reference

Cellosaurus release 49

14 July 2024

Global proteome analysis of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

14 July 2024

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

1 reference

Cellosaurus release 49

14 July 2024

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner

1 reference

Cellosaurus release 49

14 July 2024

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR

1 reference

Cellosaurus release 49

14 July 2024

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 49

14 July 2024

A map of mobile DNA insertions in the NCI-60 human cancer cell panel.

1 reference

Cellosaurus release 49

14 July 2024

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 49

14 July 2024

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 49

14 July 2024

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

1 reference

Cellosaurus release 49

14 July 2024

Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location

1 reference

Cellosaurus release 49

14 July 2024

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

bronchiolo-alveolar adenocarcinoma

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/BTO_0004182

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/CLO_0037034

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

Cell Line Ontology ID

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54908034&oldid=2258428805"